Actuate Therapeutics advances Ewing Sarcoma trial following positive Phase 1 results

Citius Oncology prices USD9.0m public offering

Innovent Biologics' Phase 1 anti-CLDN18.2 ADC (IBI343) results published in Nature Medicine

Akeso reports first patient enrolled in Phase III Ivonescimab trial for advanced metastatic colorectal cancer treatment

Senhwa Biosciences reports first patient dosed in Pidnarulex (CX-5461) study in patients with advanced solid tumours

Varian launches IntelliBlate in Europe, expanding image-guided microwave ablation for cancer care

Imugene announces Azer-cel Phase 1b clinical trial data

CARsgen successfully defends European GPC3 CAR-T patent

Oncolytics Biotech to host key opinion leader webinar focusing on pancreatic and gastrointestinal cancers

IGI and AbbVie enter global licensing agreement for ISB 2001

European Commission approves TEVIMBRA with chemotherapy for first-line treatment of nasopharyngeal carcinoma

Pfizer and Astellas report XTANDI plus leuprolide improves survival in high-risk prostate cancer patients

Taiho Oncology and Taiho Pharmaceutical's INQOVI/venetoclax combination sNDA accepted by US FDA

SciBase introduces Nevisense pilot at Florida research university

Exact Sciences secures Medicare coverage for Oncodetect MRD test in colorectal cancer